The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 04, 2020

Filed:

Apr. 07, 2017
Applicant:

Lifespan Ip Holdings, Llc, Malvern, PA (US);

Inventors:

Daniel Finan, Philadelphia, PA (US);

Pavel Vereshchetin, Moscow, RU;

Assignee:

LifeSpan IP Holdings, LLC, Malvern, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 5/172 (2006.01); G05B 13/04 (2006.01); G16H 20/17 (2018.01); G16H 50/50 (2018.01); G16H 40/63 (2018.01); A61M 5/142 (2006.01);
U.S. Cl.
CPC ...
A61M 5/1723 (2013.01); G05B 13/048 (2013.01); G16H 20/17 (2018.01); G16H 40/63 (2018.01); G16H 50/50 (2018.01); A61M 5/14244 (2013.01); A61M 5/14248 (2013.01); A61M 5/14276 (2013.01); A61M 2005/14208 (2013.01); A61M 2005/1726 (2013.01); A61M 2205/3561 (2013.01); A61M 2205/505 (2013.01); A61M 2230/201 (2013.01);
Abstract

An artificial pancreas system includes a continuous glucose monitoring device, a drug delivery device configured to exchange data with the continuous glucose monitoring device and containing a control algorithm, and possibly a remote controller configured to exchange data with the drug delivery device. The algorithm contains an insulin-glucose model, but is decoupled mathematically from the insulin injected by the user to offset the ingested carbohydrates. The control algorithm is designed to calculate two versions of insulin-on-board-patient-facing insulin-on-board (PFIOB) and system-facing insulin-on-board (SFIOB) to properly parse boluses and inform the system of only the insulin that is intended for high glucose correction, but not carbohydrate offsetting.


Find Patent Forward Citations

Loading…